2BBBullish & Bearish
Mineralys Therapeutics, Inc. (MLYS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 26 out of 100.
Mineralys Therapeutics, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 0 | Very Low |
| Founded | 2019 |
| Employees | 76 |
| 52-week range | $12.59 – $47.65 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.575 | — | $0.00 |
| 2026-08-11 | — | -0.5457 | — | $0.00 |
| 2026-05-11 | — | -0.4838 | — | $0.00 |
| 2026-03-18 | — | -0.5435 | — | $0.00 |